LAURA LEAST: Open Payments
NPI 1619451648 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,450 in 110 payments from 13 companies in 2025. Trend: 2023 $17 · 2024 $1,805 · 2025 $2,450
Food & beverage: $2,366Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $909 |
| Ardelyx, Inc. | 11 | $361 |
| Janssen Biotech, Inc. | 13 | $257 |
| Phathom Pharmaceuticals, Inc. | 11 | $205 |
| Aimmune Therapeutics, Inc. | 11 | $182 |
| Gilead Sciences, Inc. | 5 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $88 |
| PFIZER INC. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Madrigal Pharmaceuticals | 2 | $59 |
Products named: IBSRELA, RINVOQ, VOQUEZNA, SKYRIZI, ZENPEP, TREMFYA, LINZESS, VIBERZI.
Industry payments across FL — which companies pay providers there.
